Science Group Plc · LSE:SAG
Science — Sagentia Group — H1 2011 Earnings Presentation
11 slides from Science's earnings presentation, July 2011
Slide 1: Interim Results Presentation July 2011
Interim Results Presentation July 2011
Slide 2: Sagentia Group plc
Sagentia Group plc Technology & Product Development Company • Outsourced R&D • Predominantly time-and-materials consultancy (H1 2010 predominantly fixed price projects) • Sectors : Medical, Consumer & Industrial • Based in Harston, near Cambridge • Significant freehold property (Approx half occupied
Slide 3: Summary of H1 2011 - Financials
Summary of H1 2011 - Financials Continued Revenue Growth • Revenue of £12.6m (H1 2010: £9.8m) : 27.6% growth • Enhanced by exceptional product revenue in H1 2011 • Consulting fees of £9.7m (H1 2010: £8.0m) : 21.8% growth Continued Margin Improvement • Operating Profit of £2.3m (H1 2010: £1.1m) : 101
Slide 4: Summary Financial Performance
Summary Financial Performance 15 3.0 2.0 10 1.0 Revenue £m Profit/Loss £m Revenue 0.0 Operating Profit/Loss 5 -1.0 PBT -2.0 2009 includes revenue from disposed/discontinued activities 0 -3.0 H1-09 H2-09 H1-10 H2-10 H1-11 4 © Sagentia 2010
Slide 5: Revenue Breakdown
Revenue Breakdown 14 12 Discontinued/ 10 Disposed IT Services (M5N) Revenue £m 8 Property Tenants 6 Product and licence income 4 Recharged Project Materials 2 Consulting Fees 0 H1-09 H2-09 H1-10 H2-10 H1-11 5 © Sagentia 2010
Slide 6: Revenue Breakdown
Revenue Breakdown Total Revenue Consulting Fees Consulting Fees 6% Medical 5% Recharged 13% Project Consumer 5% Materials 15% Industrial Property 7% Tenants Manage5Nines 77% 72% Product and NTRI 6 © Sagentia 2010
Slide 7: Segmental Analysis
Segmental Analysis Business Sectors • Medical sector was strong in H1, accounting for 72% of consulting fees • Sagentia reputation for successful medical device developments increasing • Consumer sector had a slower start but recovered in Q2 • Industrial sector was quieter Geographic • Approx 77% of
Slide 8: Balance Sheet (extracted information)
Balance Sheet (extracted information) 30 June 2010 31 Dec 2010 30 June 2011 £m £m £m Cash 12.5 16.4 17.7 Borrowings •Bank (5.5) (7.8) (7.4) •Other borrowings (0.4) (0.1) (0.2) Equity Investments 1.4 1.0 0.8 • BVCA valuation. Realisable value indeterminate. Freehold Property 13.9 13.9 13.8 • Last val
Slide 9: Other Matters
Other Matters Operational • Closure of Hong Kong site – migration of work to Harston and Boston • Expansion of Boston facility in H2 2011 • Investment in sales and account management resources Corporate • Disposal of Sensortec and Atranova shareholdings • Buy out of minority shareholding in M5N Busi
Slide 10: Summary
Summary Turnaround completed in 2010. Performance sustained in H1 2011 • Substantially de-risked operating model Strong organic growth in excess of 20% Strong operating margins • Enhanced by exceptional product revenue in H1 2011 • Board will balance margin and investment • Revenue per head increase
Slide 11: Contact details
www.sagentia.com info@sagentia.com ja Ltd Harston Mill Harston Cambridge CB22 7G UK T, +44 1223 875200 Inc One Broadway 14th Floor Cambridge MA 02142 USA T. +1 617 401 3170 www.sagentia.com info@sagentia.com Sagentia is listed on the London Stock Exchange (SAG.L) SAGENTIA